WIN-MTB-2024017 – WIN International Molecular Tumor Board: A 48-year-old female with multiple primary cancers...Impact Journals LLC
Targeting RBM5 may help disrupt ‘undruggable’ MYC in childhood leukemia...St. Jude Children's Research Hospital